Prescriber's Corner

Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma

Vivian Tsang, PharmD, BCOP

From Cedars-Sinai Medical Center, Los Angeles, California

The author has no conflicts of interest to disclose.

Correspondence to: Vivian Tsang, PharmD, BCOP, Cedars-Sinai Medical Center, 8700 Beverley Boulevard, Los Angeles, CA 90048. E-mail: tsangv@cshs.org


J Adv Pract Oncol 2012;3:184–190 | DOI: 10.6004/jadpro.2012.3.3.8 | © 2012 Harborside Press®


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here